[A decade of breakthroughs in high-quality clinical research on acupuncture: deep transformation and paradigm reconstruction marching towards evidence-based medicine].
Researchers
Jiani Wu, Tao Yang, Zhishun Liu
Abstract
In the past decade (2015-2025), acupuncture clinical trials have achieved leapfrog development, from empirical medicine to evidence-based medicine. Many multicenter randomized controlled trials with rigorous designs and adequate sample sizes have been published in top-tier international journals including <i>The Journal of The American Medical Association</i> (<i>JAMA</i>), <i>British Medical Journal</i> (<i>BMJ</i>), <i>Annals of Internal Medicine</i>, and <i>Journal of Clinical Oncology</i> (<i>JCO</i>). It has significantly enhanced the scientific credibility of acupuncture efficacy, leading the World Health Organization to include acupuncture in the Traditional Medicine Chapter of the 11th Revision of the International Classification of Diseases (ICD-11); and has prompted the inclusion of acupuncture therapy in the medical insurance system in many countries. The research hotspots focus on chronic pain, functional gastrointestinal diseases, urinary and pelvic floor dysfunction, supportive therapy for tumors, perioperative management, and neuropsychiatric disorders. Many findings have been cited in authoritative guidelines from both domestic and international sources, significantly elevating the status of acupuncture in the global healthcare system. The research paradigm of acupuncture in China is shifting from "verifying efficacy" to "optimizing pathways", with greater emphasis on objective outcome indicators, long-term efficacy observation, and the accumulation of real-world data. In the future, the emerging technologies will be deeply integrated, such as artificial intelligence with big data and virtual/augmented reality. It is expected to further facilitate the accumulation of high-quality evidence, the construction of precise prediction model of efficacy, and the innovation of intelligent diagnosis and treatment paradigms. It will propel acupuncture from a "supplementary therapy" to an integrative medicine, and reshape disciplinary research paradigms and international development frameworks. 2015-2025年,针刺临床研究实现了由经验医学向循证医学的深度转型,取得了跨越式发展。多项设计严谨、样本充足的多中心随机对照试验相继发表在《美国医学会杂志》(<i>JAMA</i>)、《英国医学杂志》(<i>BMJ</i>)、《内科学年鉴》(<i>Annals of Internal Medicine</i>)、《临床肿瘤学杂志》(<i>JCO</i>)等国际顶级期刊,显著增强了针刺疗效的科学可信度,也推动世界卫生组织将针刺纳入《国际疾病分类第十一次修订本(ICD-11)》传统医学章节,并促使多个国家将针刺疗法纳入医疗保险体系。研究热点聚焦于慢性疼痛、功能性胃肠病、泌尿及盆底功能障碍、肿瘤支持治疗、围手术期管理及精神与神经疾病等领域,部分成果已被国内外权威指南引用,显著提升了针刺在国际医疗体系中的地位。中国针刺研究范式正由“验证疗效”向“优化路径”转变,更加重视客观结局指标、长期疗效观察及真实世界数据的积累。未来,人工智能与大数据、虚拟/增强现实等新兴技术的深度融合,有望进一步助力高质量证据积累、精准疗效预测模型的构建和智慧诊疗模式的创新。这一趋势将推动针刺从“补充治疗”迈向整合医学,并重塑学科研究范式与国际化发展格局。.Source: PubMed (PMID: 42618252)View Original on PubMed